Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
16 , R143 (2014)
baseline 247.8 lb (Wegovy HD and placebo), 256.9 lb (Wegovy 2.4 mg), and BMI 39.9 kg/m 2 (N=1,407, randomized 5:1:1 to Wegovy HD injection 7.2 mg, Wegovy injection 2.4 mg, or placebo)
Liraglutide (Saxenda): The Original Weight Loss GLP-1 Liraglutide was the first GLP-1 receptor agonist to receive FDA approval specifically for chronic weight management, doing so in 2014 under the brand name Saxenda
Sikiri P, Seiwerth S, Rucman R, et al
US$ 25.40
US$ 25.77
US$ 27.28
